Cardax puts synthetic astaxanthin finished product on market
A synthetic astaxanthin finished product has reached the market with the release of ZanthoSyn, by Hawaiian firm Cardax.
News, Analysis & Insights on Nutrition, Supplements, and Health
A synthetic astaxanthin finished product has reached the market with the release of ZanthoSyn, by Hawaiian firm Cardax.
Carotenoid and astaxanthin production has been championed as a solution to make use of the crustacean industry’s waste. Researchers looked at the derived product’s storage stability—they found “negligible lipid oxidation” and some gradual degradation of...
A recent FDA warning letter emphasizes the importance of maintaining consistent messaging about a product to avoid crossing the disease claims line.
Industry study suggests an increased tolerance of high-intensity training when study participants consumed the cordyceps-containing PeakO2 blend.
Duffy MacKay of CRN argues that there is much in FDA's newly released New Dietary Ingredients draft guidance that represents a step forward for the industry.